Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
38 hedge funds and large institutions have $1.58M invested in Chembio diagnostics, Inc. in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
6% more funds holding
Funds holding: 36 → 38 (+2)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
32% less capital invested
Capital invested by funds: $2.33M → $1.58M (-$752K)
44% less call options, than puts
Call options by funds: $28K | Put options by funds: $50K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$30.6K |
| 2 |
Renaissance Technologies
New York
|
+$15.6K |
| 3 |
SG
StoneX Group
New York
|
+$10.9K |
| 4 |
S
SignatureFD
Atlanta,
Georgia
|
+$9.96K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Penbrook Management
New York
|
-$68K |
| 2 |
EGM
Engineers Gate Manager
New York
|
-$63.8K |
| 3 |
BlackRock
New York
|
-$50.4K |
| 4 |
VF
Virtu Financial
New York
|
-$30K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$12.4K |
CEMI Hedge Fund Activity: Q2 2022 in Review
38 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q2 2022, worth a combined $1.58M — down 32% from $2.33M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CEMI positions and 2 closed out — a net gain of 3 holders — while 8 added to existing stakes and 10 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $30.6K. The largest seller was Penbrook Management, exiting entirely with an estimated $68K sold.
- 38 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q2 2022, up from 36 in Q1 2022.
- Funds reported $1.58M of Chembio diagnostics, Inc. stock for Q2 2022, down 32% quarter-over-quarter.
- 5 funds opened new Chembio diagnostics, Inc. positions in Q2 2022 and 2 closed out, a net change of +3 holders.
- The largest Chembio diagnostics, Inc. buyer in Q2 2022 was Two Sigma Securities, an estimated $30.6K added.
- The largest Chembio diagnostics, Inc. seller in Q2 2022 was Penbrook Management, an estimated $68K sold.
Based on aggregated 13F filings for Q2 2022.